114 related articles for article (PubMed ID: 10415516)
1. The ins and outs of caveolar signaling. m2 muscarinic cholinergic receptors and eNOS activation versus neuregulin and ErbB4 signaling in cardiac myocytes.
Feron O; Zhao YY; Kelly RA
Ann N Y Acad Sci; 1999 Jun; 874():11-9. PubMed ID: 10415516
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic cholinergic signaling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation.
Feron O; Han X; Kelly RA
Life Sci; 1999; 64(6-7):471-7. PubMed ID: 10069512
[TBL] [Abstract][Full Text] [Related]
3. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes.
Feron O; Smith TW; Michel T; Kelly RA
J Biol Chem; 1997 Jul; 272(28):17744-8. PubMed ID: 9211926
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.
Han X; Kubota I; Feron O; Opel DJ; Arstall MA; Zhao YY; Huang P; Fishman MC; Michel T; Kelly RA
Proc Natl Acad Sci U S A; 1998 May; 95(11):6510-5. PubMed ID: 9600997
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes.
Zhao YY; Feron O; Dessy C; Han X; Marchionni MA; Kelly RA
Circ Res; 1999 Jun; 84(12):1380-7. PubMed ID: 10381889
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.
Feron O; Dessy C; Opel DJ; Arstall MA; Kelly RA; Michel T
J Biol Chem; 1998 Nov; 273(46):30249-54. PubMed ID: 9804784
[TBL] [Abstract][Full Text] [Related]
7. Dynamin mediates caveolar sequestration of muscarinic cholinergic receptors and alteration in NO signaling.
Dessy C; Kelly RA; Balligand JL; Feron O
EMBO J; 2000 Aug; 19(16):4272-80. PubMed ID: 10944110
[TBL] [Abstract][Full Text] [Related]
8. Regulation by cAMP of post-translational processing and subcellular targeting of endothelial nitric-oxide synthase (type 3) in cardiac myocytes.
Belhassen L; Feron O; Kaye DM; Michel T; Kelly RA
J Biol Chem; 1997 Apr; 272(17):11198-204. PubMed ID: 9111020
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.
Feron O; Belhassen L; Kobzik L; Smith TW; Kelly RA; Michel T
J Biol Chem; 1996 Sep; 271(37):22810-4. PubMed ID: 8798458
[TBL] [Abstract][Full Text] [Related]
10. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T
J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455
[TBL] [Abstract][Full Text] [Related]
11. A chimeric transmembrane domain directs endothelial nitric-oxide synthase palmitoylation and targeting to plasmalemmal caveolae.
Prabhakar P; Cheng V; Michel T
J Biol Chem; 2000 Jun; 275(25):19416-21. PubMed ID: 10787410
[TBL] [Abstract][Full Text] [Related]
12. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling.
García-Cardeña G; Oh P; Liu J; Schnitzer JE; Sessa WC
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6448-53. PubMed ID: 8692835
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae.
Chambliss KL; Yuhanna IS; Mineo C; Liu P; German Z; Sherman TS; Mendelsohn ME; Anderson RG; Shaul PW
Circ Res; 2000 Nov; 87(11):E44-52. PubMed ID: 11090554
[TBL] [Abstract][Full Text] [Related]
14. Targeting and translocation of endothelial nitric oxide synthase.
Michel T
Braz J Med Biol Res; 1999 Nov; 32(11):1361-6. PubMed ID: 10559837
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes.
Balligand JL; Kobzik L; Han X; Kaye DM; Belhassen L; O'Hara DS; Kelly RA; Smith TW; Michel T
J Biol Chem; 1995 Jun; 270(24):14582-6. PubMed ID: 7540173
[TBL] [Abstract][Full Text] [Related]
16. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything.
Goligorsky MS; Li H; Brodsky S; Chen J
Am J Physiol Renal Physiol; 2002 Jul; 283(1):F1-10. PubMed ID: 12060581
[TBL] [Abstract][Full Text] [Related]
17. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
19. The endothelial nitric-oxide synthase-caveolin regulatory cycle.
Feron O; Saldana F; Michel JB; Michel T
J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418
[TBL] [Abstract][Full Text] [Related]
20. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia.
Toporsian M; Gros R; Kabir MG; Vera S; Govindaraju K; Eidelman DH; Husain M; Letarte M
Circ Res; 2005 Apr; 96(6):684-92. PubMed ID: 15718503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
